(Q33331088)

25 July 2017

title

Circulating levels of transforming growth factor-beta1 and lymphokines among children with hemolytic uremic syndrome (English)

1 reference

25 July 2017

Proulx F

1

1 reference

25 July 2017

Litalien C

2

1 reference

25 July 2017

Turgeon JP

3

1 reference

25 July 2017

Mariscalco MM

4

1 reference

25 July 2017

Seidman E

5

1 reference

25 July 2017

publication date

1 January 2000

1 reference

American Journal of Kidney Diseases

25 July 2017

published in

1 reference

25 July 2017

volume

35

1 reference

25 July 2017

issue

1

1 reference

25 July 2017

page(s)

29-34

1 reference

The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970297-6

7 January 2021

Epidemiology of hemolytic-uremic syndrome in Canadian children from 1986 to 1988. The Canadian Pediatric Kidney Disease Reference Centre

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970297-6

7 January 2021

Escherichia coliO157:H7 and the Hemolytic–Uremic Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970297-6

7 January 2021

A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970297-6

7 January 2021

Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970297-6

7 January 2021

Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970297-6

7 January 2021

Verotoxin receptor glycolipid in human renal tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970297-6

7 January 2021

Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970297-6

7 January 2021

Inflammatory mediators in Escherichia coli O157:H7 hemorrhagic colitis and hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970297-6

7 January 2021

Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970297-6

7 January 2021

Soluble P‐selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970297-6

7 January 2021

Soluble circulating cell adhesion molecules in haemolytic uraemic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970297-6

7 January 2021

The role of interleukin-1 in disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970297-6

7 January 2021

Transforming growth factor beta and interleukin-1: a paradigm for opposing regulation of haemopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970297-6

7 January 2021

Escherichia coli O157:H7 infection mimicking Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970297-6

7 January 2021

Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: a mechanism for the failure of long-lived antibody response to dysenteric disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970297-6

7 January 2021

Cytokine secretion in acute shigellosis is correlated to disease activity and directed more to stool than to plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970297-6

7 January 2021

Transforming growth factor-beta in disease: the dark side of tissue repair

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970297-6

7 January 2021

Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970297-6

7 January 2021

10.1016/S0272-6386(00)70297-6

Identifiers

DOI

1 reference

25 July 2017

1 reference